Citation Impact
Citing Papers
Activity-Dependent Internalization of Smoothened Mediated by ß-Arrestin 2 and GRK2
2004 StandoutScienceNobel
HMGA2 Is a Driver of Tumor Metastasis
2013
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
2006
Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
2008 StandoutScience
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer
2010
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
The role of cancer registries in cancer control
2008
Dendritic cells: On the move from bench to bedside
2001
The role of chemoattraction in cancer metastases
2001
Inflammation and cancer
2002 StandoutNature
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Chemokines in neoplastic progression
2004
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes
2018
The dendritic cell and human cancer vaccines
2000
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Immunology and immunotherapy approaches for prostate cancer
2007
Genetic instabilities in human cancers
1998 StandoutNature
Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment
1999
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
2017
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease
1999
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Lymphangiogenesis in development and human disease
2005 StandoutNature
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
1991 Standout
Global cancer statistics
2011 Standout
Pathological prognostic factors in breast cancer
1999 Standout
The National Cancer Data Base report on cutaneous and noncutaneous melanoma
1998 Standout
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
2008 StandoutNature
The evolution of the population-based cancer registry
2006
The microenvironment of the tumour–host interface
2001 StandoutNature
Immunity, Inflammation, and Cancer
2010 Standout
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
1995
Molecular genetics of prostate cancer
2000
Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
1996
Identification of a cold receptor reveals a general role for TRP channels in thermosensation
2002 StandoutNatureNobel
Guidelines 2000 for Colon and Rectal Cancer Surgery
2001
A TRP Channel that Senses Cold Stimuli and Menthol
2002 StandoutNobel
Immunotherapy for prostate cancer
2006
Cancer screening in the United States, 2013
2013
Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread
1999
Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function
2000
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
Display cloning: functional identification of natural product receptors using cDNA-phage display
1999
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
2018
B7-H3 and B7-H4 expression in non-small-cell lung cancer
2006
Accumulated allelic losses in the development of invasive urothelial cancer
1993 StandoutNobel
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
2010 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging
2004
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
1989 Standout
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
2015
DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells
2000
Smoothened Activates Gαi-mediated Signaling in Frog Melanophores
2000
An image contrast agent selectively activated by prostate specific antigen
2005
Octreotide in the Management of Hormone-Refractory Prostate Cancer
2001
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides
1998
Ductal carcinoma in situ of the breast
1997
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Dendritic Cell Vaccines for Cancer Immunotherapy
1999
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
2010
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking
1998 StandoutScienceNobel
Molecular insights into cancer invasion: strategies for prevention and intervention.
1995
Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.
2001
Clinical use of Prostate Specific Antigen in Patients with Prostate Cancer
1989
A Prospective Evaluation of Plasma Prostate-Specific Antigen for Detection of Prostatic Cancer
1995
Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications
2019
Memory--a Century of Consolidation
2000 StandoutScience
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
2006 StandoutNature
A Strategy for the Selective Imaging of Glycans Using Caged Metabolic Precursors
2010 StandoutNobel
T Cell Activity After Dendritic Cell Vaccination Is Dependent on Both the Type of Antigen and the Mode of Delivery
2000
Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen
1990
Transrectal ultrasound in the diagnosis of prostate cancer: Location, echogenicity, histopathology, and staging
1985
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
1998 StandoutScience
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer
1977 Standout
Polycythemia: Mechanisms and Management
1981
Allelic Loss of Chromosome 17P in Urothelial Cancer: Strong Association with Invasive Phenotype
1992 StandoutNobel
Expression profiling with arrays of randomly disrupted genes in mouse embryonic stem cells leads to in vivo functional analysis
2004 StandoutNobel
Geographic pathology of latent prostatic carcinoma
1982
Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy
1988
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Printing Proteins as Microarrays for High-Throughput Function Determination
2000 StandoutScience
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA
2001
Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt.
2003
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
1997
Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment)
1985
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Global cancer statistics, 2012
2015 Standout
Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.
2000
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
2014 Standout
Testis tumors: Review of 125 cases at the Cleveland clinic
1975
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.
2006
Is There a Role for SV40 in Human Cancer?
2006
Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia
1990
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Works of Gerald P. Murphy being referenced
Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP‐based enzyme‐linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement
1995
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma
1998
The relationship of prostate‐specific antigen to digital rectal examination and transrectal ultrasonography: Findings of the American cancer society national prostate cancer detection project
1992
CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells
1998
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases
1998
The growth and maturation of the national cancer data base
1997
Development of dendritic-cell based prostate cancer vaccine
2000
Report from the International Union Against Cancer (UICC) Tumor Biology Committee
1999
The National Cancer Data Base report on patterns of hospital reporting
1996
Evaluation and comparison of two new prostate carcinoma markers: Free-prostate specific antigen and prostate specific membrane antigen
1996
Transrectal ultrasound microbubble contrast angiography of the prostate
1997
Tumor grade and stage as prognostic variables in upper tract urothelial tumors
1988
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer
1997
Molecular characterization of CXCR–4: A potential brain tumor-associated gene
1998
Monoclonal antibody 7E11.C5 staining of viable LNCaP cells
1997
In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy
1995
Workgroup 4: Spontaneous prostate carcinoma in dogs and nonhuman primates
1998
Western blot assay for prostate‐specific membrane antigen in serum of prostate cancer patients
1994
Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity
1996
American Cancer Society guidelines for the early detection of prostate cancer
1997
Application of the differential hybridization of Atlas™ human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue
1998
Presentation of prostate tumor antigens by dendritic cells stimulates T‐cell proliferation and cytotoxicity
1996
Transrectal ultrasonography of the prostate
1984
SV40 Neutralizing Antibodies in Sera of US Residents without History of Polio Immunization
1971 Nature
Clinical Significance of Serum Alkaline Phosphatase Isoenzyme Levels in Advanced Prostatic Carcinoma
1978
A report of the workshops on the current status of the histologic grading of prostate cancer
1979
Erythropoietin levels in patients with renal tumors or cysts
1970
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone
1983
The national cancer data base report on recent hospital cancer program progress toward complete American joint committee on cancer/TNM staging
1997
The occurrence of SV40‐neutralizing antibodies in sera of patients with genitourinary carcinoma
1971
Histologic Grading of Primary Prostatic Cancer: A New Approach to an Old Problem
1980
Management and survival of female breast cancer: Results of a national survey by the American college of surgeons
1980
Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen
1998
Correlation of estrogen and androgen receptor status in prostatic disease measured by high pressure liquid chromatography
1984
Use of human prostate-specific antigen in monitoring prostate cancer.
1981
Management and survival of female patients with “minimal” breast cancer: As observed in the long-term and short-term surveys of the american college of surgeons
1981
Estrogen and progestin receptors in human prostatic carcinoma
1985
Surgical Management of Testis Tumor
1974
Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasms
1981
Combination radical surgery and multiple sequential chemotherapy for the treatment of advanced carcinoma of the testis (stage III)
1976
Erythropoietin activity in anephric humans given prolonged androgen treatment
1971
A comparison of estrogen and androgen receptor levels in human prostatic tissue from patients with non-metastatic and metastatic carcinoma and benign prostatic hyperplasia
1985
Effect of actinomycin D‐containing lipid vesicles on murine renal adenocarcinoma
1980
Prostatic acid phosphatase — the developing experience
1979
Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial.
2000
What's new in tumor markers for prostate cancer?
1986
Comparison of serum PSMA, PSA levels with results of cytogen-356 ProstaScint® scanning in prostatic cancer patients
1997
American Joint Committee on Cancer Prognostic Factors Consensus Conference
1999